FDA Clearance Tracker · P020004-S166
GORE EXCLUDER AAA Endoprosthesis
Last checked: Nov 20, 2026Latest source record: Feb 5, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Feb 5, 2020
Approved
Time to decision
180 days
Received Aug 9, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020004-S166
- Device name
- GORE EXCLUDER AAA Endoprosthesis
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Phonix, AZ
- Received
- Aug 9, 2019
- Decided
- Feb 5, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020004
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for use of an alternate deployment fiber with the Gore EXCLUDER Low-Profile Aortic Extender device component.
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
- GORE® VIABAHN® FORTEGRA Venous StentBreakthroughPMA
P250017 · Decided Dec 19, 2025 · 182 days after receipt
Device type: Stent, vena cava (QTL) · Cardiology
K250410 · Decided Jun 2, 2025 · 109 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.